Antoine G.
- Country
- France
- Department
- ICU
Research Overview
- Prognostic Impact of Early Low Plasma Oseltamivir Carboxylate Concentration in Critically Ill Adults with Severe Influenza in Intensive Care
- Evaluation of Recombinant Human Interferon Gamma 1b for Reducing Secondary Infections in ICU Patients with Sustained Immunosuppression
- Phase I Single-Blind Trial Evaluating Safety and Local Immune Activation of Toll-Like Receptor 5 Agonist FLAMOD in Pneumonia Patients
Data & Insights
Has run more than one trial at 7 of 30 partner sites.
Specializations
Respiratory Infections
This investigator specializes in the treatment of severe respiratory conditions, with particular focus on severe influenza infections requiring intensive care management and pneumonia. Their research encompasses innovative therapeutic approaches for patients requiring mechanical ventilation in critical care settings.
- Severe influenza management
- Critical respiratory care
- Mechanical ventilation protocols
Their work includes evaluation of treatment efficacy in intensive care unit settings.
Immunotherapy
The investigator focuses on innovative immunological interventions, particularly studying interferon gamma therapy and immune modulation in critical care patients. Their research addresses sustained immunosuppression in intensive care settings.
- Immune system modulation
- Secondary infection prevention
- ICU immunotherapy protocols
Their work examines standardized immunotherapy approaches for critically ill patients.
Novel Therapeutic Approaches
The investigator explores advanced therapeutic interventions, including toll-like receptor agonists and aerosol-based treatments. Their research encompasses evaluation of local immune activation through innovative delivery methods.
- Aerosol-based therapeutics
- Immune response activation
- Safety evaluation protocols
Their research includes assessment of novel therapeutic agents and delivery systems.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.